Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
This study will evaluate the efficacy and safety of MabThera/Rituxan (rituximab) in treatment-naive patients with non-bulky follicular non-Hodgkin`s lymphoma. The anticipated time on study treatment is 3 months.
Inclusion criteria
- Non-Hodgkin's Lymphoma